GYRE Gyre Therapeutics, Inc. - Common Stock
$6,80
Cena · Sie 18, 2026
Dane fundamentalne na dzień Sie 7, 2026
Zakres 52 tyg.
$5–$9
34% of range
Ocena Analityków
BUY
9 analysts
Cena Docelowa
$19
+175% upside
P/E (TTM)
340.0
ROE
11.7%
Marża Zysku Netto
8.5%
GYRE Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$6.80
Kapitalizacja Rynkowa
$621M
P/E (TTM)
340.0
EPS (TTM)
$0.02
Przychody (TTM)
$117M
Stopa dywidendy
—
ROE
11.7%
D/E Dług/Kapitał
—
Zakres 52 tyg.
$5 – $9
GYRE Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$117M
2017-12-31
→
2025-12-31
EPS
$0.02
2021-12-31
→
2025-12-31
Wolny przepływ pieniężny
$-180.0K
2016-12-31
→
2025-12-31
Marże
8.5%
2023-12-31
→
2024-12-31
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
GYRE
Mediana porównawcza
P/E (TTM)
340.0
19.6
P/S (TTM)
5.3
6.4
P/B
5.9
2.6
Price / FCF (Cena / FCF)
-3449.6
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
GYRE
Mediana porównawcza
Operating Margin (Marża Operacyjna)
9.8%
—
Net Profit Margin (Marża Zysku Netto)
8.5%
-104.2%
ROA
6.8%
-40.3%
ROE
11.7%
-42.4%
ROIC
7.4%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
GYRE
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
5.6
5.4
Quick Ratio (Wskaźnik Szybkości)
4.6
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
GYRE
Mediana porównawcza
Revenue YoY (Przychody R/R)
10.2%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
4.5%
—
Revenue CAGR 5Y (Przychody CAGR 5L)
41.0%
—
EPS YoY
-60.0%
—
Net Income YoY (Zysk Netto R/R)
-44.8%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
GYRE
Mediana porównawcza
Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR
Stopa Dywidendy
—
Wskaźnik Wypłaty Dywidendy
—
CAGR dywidendy 5-letni
—
| Data ex-dywidendy | Kwota |
|---|---|
| 13 stycznia 2023 | $3,6000 |
| 21 września 2022 | $21,4500 |
| 20 sierpnia 2015 | $896,1750 |
GYRE Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
9 analityków
- Mocne kupno 3 33,3%
- Kup 5 55,6%
- Trzymaj 1 11,1%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
3 analityków · 2026-08-14
Mediana
$18.00
Średnia
$18.67
← Poniżej wszystkich celów
$6.80
Niski
$18.00
Wysoki
$20.00
Średni cel
$18.00
+164,7%
Średnia cel
$18.67
+174,5%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
0.01%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $-0.12 | $-0.09 | -0.03% |
| 31 marca 2026 | $-0.04 | $-0.07 | 0.03% |
| 31 grudnia 2025 | $0.05 | $0.06 | -0.01% |
| 30 września 2025 | $0.08 | $0.03 | 0.05% |
| 30 czerwca 2025 | $0.02 | $0.03 | -0.01% |
| 31 marca 2025 | $0.03 | $0.03 | -0.00% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| GYRE | $645M | 353.0 | 10.2% | 8.5% | 11.7% | — |
| STTK | $231M | -5.2 | -82.5% | -4880.9% | -70.0% | — |
| RGNX | $733M | -3.8 | 104.5% | -113.8% | -122.5% | — |
| BBOT | $1.00B | -2.9 | — | — | -146.2% | — |
| IRWD | $550M | 22.5 | -15.7% | 8.1% | -8.5% | — |
| ALLO | $314M | -1.6 | -76.8% | — | -59.9% | — |
| SGMT | — | -3.7 | — | — | -42.3% | — |
| TECX | $391M | -5.2 | — | — | -27.7% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 17
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $117M | $106M | $113M | $102M | $7M | $21M | · | $6.0K | $1M | · | · | $275.0K | |
| Cost of Revenue | $5M | $4M | $5M | $5M | · | · | · | · | · | · | · | · | |
| Gross Profit | · | $102M | $109M | $97M | · | · | · | · | · | · | · | · | |
| R&D Expense | $14M | $12M | $14M | · | $69M | $53M | $44M | $21M | $13M | $12M | $6M | $5M | |
| SG&A Expense | $21M | $16M | $15M | $17M | $19M | $16M | $13M | $12M | $10M | $9M | $10M | $4M | |
| Operating Expenses | $105M | $90M | $176M | $88M | $95M | $78M | $57M | $34M | $23M | $21M | $16M | $9M | |
| Operating Income | $11M | $16M | $-67M | $9M | $-88M | $-57M | $-57M | $-34M | $-22M | $-20M | $-14M | $-8M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | $1M | $23.0K | |
| Other Non-op | $-2M | $-2M | $-2M | · | $-78.0K | $-91.0K | $-39.0K | $2M | $-1.0K | $86.0K | $131.0K | $575.0K | |
| Pretax Income | $14M | $23M | $-77M | $9M | $-88M | · | · | · | · | · | · | $-29M | |
| Income Tax | $5M | $5M | $9M | $5M | · | · | · | · | · | · | · | $3M | |
| Net Income | $10M | $18M | $-85M | $4M | $-88M | $-56M | $-55M | $-30M | $-22M | $-17M | $-15M | $-7M | |
| EPS (Basic) | $0.06 | $0.14 | $-1.41 | $0.04 | $-2.87 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $0.02 | $0.05 | $-1.41 | $0.03 | $-2.87 | · | · | · | · | · | · | · | |
| Shares (Basic) | 89,344,622 | 85,094,948 | 65,831,675 | 63,588,119 | 30,640,977 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 103,180,037 | 102,293,526 | 65,831,675 | 75,686,406 | 30,640,977 | · | · | · | · | · | · | · | |
| EBITDA | $14M | $18M | $-66M | $-8M | · | $-57M | $-57M | · | $-22M | $-20M | $-13M | $-29M |
Bilans 27
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $49M | $12M | $34M | $25M | $44M | $30M | $15M | $31M | $14M | $10M | $29M | $2M | |
| Short-term Investments | $15M | $15M | · | · | $3M | $49M | $61M | $89M | $18M | $7M | $3M | $51M | |
| Receivables | $31M | $20M | $15M | · | $2M | $3M | $15M | · | · | · | · | $141.0K | |
| Inventory | $10M | $6M | $4M | $6M | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $10M | $3M | · | $2M | $3M | $7M | $4M | $4M | $1M | $958.0K | $2M | $103.0K | |
| Other Current Assets | $1M | $1M | $1M | $843.0K | · | · | · | · | · | · | · | · | |
| Current Assets | $149M | $65M | $57M | $50M | $51M | $90M | $96M | $124M | $39M | $38M | $69M | $2M | |
| PP&E (Net) | $28M | $24M | $23M | $18M | $970.0K | $433.0K | $304.0K | $386.0K | $276.0K | $444.0K | $698.0K | $911.0K | |
| PP&E (Gross) | $39M | $29M | $28M | $22M | · | · | · | $671.0K | $2M | $2M | $6M | $8M | |
| Accum. Depreciation | $11M | $6M | $4M | $4M | · | · | $400.0K | $300.0K | $2M | $2M | $6M | $7M | |
| Intangibles | $5M | $273.0K | $273.0K | $297.0K | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $8M | $3M | $995.0K | $3M | $472.0K | $528.0K | $257.0K | $543.0K | $128.0K | · | · | $12.0K | |
| Total Assets | $220M | $125M | $117M | $85M | $56M | $95M | $99M | $125M | $40M | $38M | $70M | $3M | |
| Accounts Payable | $1M | $108.0K | $355.0K | $122.0K | $6M | $6M | $4M | $1M | $747.0K | $837.0K | $939.0K | $249.0K | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | $3M | |
| Current Liabilities | $24M | $20M | $20M | $12M | $14M | $18M | $29M | $5M | $9M | $22M | $38M | $2M | |
| Capital Leases | $2M | $885.0K | $199.0K | $121.0K | $408.0K | $981.0K | $1M | · | · | · | · | · | |
| Other Non-current Liabilities | $2M | $7.0K | $49.0K | $55.0K | · | · | · | · | · | · | · | · | |
| Total Liabilities | $31M | $27M | $38M | $13M | $15M | $19M | $30M | $5M | $9M | $22M | $38M | $3M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Common Stock | $91.0K | $86.0K | $77.0K | $64.0K | $31.0K | $22.0K | $12.0K | $12.0K | $6.0K | $1.0K | $1.0K | $34.0K | |
| Paid-in Capital | $173M | $136M | $68M | $33M | $444M | $391M | $327M | $323M | $204M | $164M | $162M | $7M | |
| Retained Earnings | $-113M | $-73M | $-86M | $7M | $-403M | $-315M | $-259M | $-203M | $-173M | $-148M | $-131M | $-116M | |
| AOCI | $-908.0K | $-3M | $-2M | $-392.0K | · | $5.0K | $34.0K | $-4.0K | · | $-1.0K | $1.0K | $4.0K | |
| Stockholders' Equity | $62M | $63M | $-16M | $43M | $41M | $76M | $68M | $120M | $31M | $16M | $31M | $-109M | |
| Liabilities + Equity | $220M | $125M | $117M | $85M | $56M | $95M | $99M | $125M | $40M | $38M | $70M | $3M | |
| Shares Outstanding | 91,314,007 | 86,307,544 | 76,595,616 | 63,588,119 | 31,409,707 | 22,097,820 | 12,040,835 | 11,954,528 | 6,081,230 | 801,756 | 762,005 | 370,944 |
Przepływy pieniężne 19
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $1M | $1M | $290.0K | $138.0K | $146.0K | $149.0K | $173.0K | $389.0K | $470.0K | $680.0K | |
| Stock-based Comp | $7M | $831.0K | $7M | $13M | $3M | $4M | $3M | $3M | $863.0K | $635.0K | $326.0K | $244.0K | |
| Deferred Tax | $-1M | $-1M | $-834.0K | $-890.0K | · | · | · | · | · | · | · | $72.0K | |
| Amort. of Intangibles | $576.0K | $38.0K | $100.0K | $200.0K | · | · | · | · | · | · | · | · | |
| Restructuring | · | · | · | $1M | $4M | · | · | · | $0 | · | · | · | |
| Other Non-cash | $-17M | $-23M | $104M | $-26M | · | $-3M | $8M | · | $585.0K | $-3M | $-5M | $-6M | |
| Operating Cash Flow | $1M | $-4M | $26M | $11M | $-84M | $-55M | $-44M | $-29M | $-20M | $-18M | $-19M | $-6M | |
| CapEx | $1M | $2M | $9M | $5M | $839.0K | · | $64.0K | $376.0K | $23.0K | $468.0K | $272.0K | $4.0K | |
| Investing Cash Flow | $-474.0K | $-20M | $-20M | $-14M | $48M | $10M | $27M | $-71M | $-11M | · | · | · | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | $-1M | |
| Stock Issued | · | $773.0K | · | · | · | · | · | · | $5M | $958.0K | · | $296.0K | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | $82.0K | · | |
| Net Stock Activity | · | $773.0K | · | · | · | · | · | · | $5M | $958.0K | $-82.0K | $296.0K | |
| Dividends Paid | · | · | · | $45M | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $24M | $2M | $2M | $-45M | $50M | $60M | $327.0K | $111M | $21M | · | · | · | |
| Net Change in Cash | $25M | $-22M | $8M | $-5M | $14M | $15M | $-16M | $11M | $-10M | $-19M | $28M | $-1M | |
| Taxes Paid | $6M | $9M | $6M | $6M | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-180.0K | $-6M | $17M | · | · | · | $-44M | · | $-20M | $-19M | $-19M | $-34M | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | · | $-35M |
Rentowność 8
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 96.3% | 95.9% | · | · | · | · | · | · | · | · | · | |
| Operating Margin | 9.8% | 15.3% | -59.3% | · | · | -273.9% | · | · | · | · | · | -10805.1% | |
| Net Margin | 8.5% | 16.9% | -75.3% | · | · | -268.5% | · | · | · | · | · | -11862.9% | |
| Pretax Margin | 12.4% | 21.9% | -67.8% | · | · | · | · | · | · | · | · | -10596.0% | |
| EBITDA Margin | 12.0% | 16.8% | -58.3% | · | · | -273.2% | · | · | · | · | · | -10677.5% | |
| ROA | 6.8% | 14.8% | -84.9% | -19.6% | · | -58.2% | -49.4% | · | -55.6% | -31.5% | -40.7% | -25.3% | |
| ROE | 11.7% | 75.4% | 387.3% | -214.5% | · | -66.1% | -73.8% | · | -92.0% | -71.4% | 37.9% | -1073.6% | |
| ROIC | 7.4% | 19.7% | 471.8% | 41.4% | · | · | · | · | · | · | · | -30.5% |
Płynność i wypłacalność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.6 | 3.3 | 2.9 | 1.7 | · | 5.0 | 3.3 | · | 4.5 | 1.7 | 1.8 | 37.1 | |
| Quick Ratio | 4.6 | 2.4 | 1.7 | 1.3 | · | 4.6 | 3.2 | · | 3.7 | 0.8 | 0.9 | 36.9 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | -9.3 | -1291.9 |
Efektywność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.9 | 1.1 | · | · | 0.2 | · | · | · | · | · | 0.0 | |
| Inventory Turnover | · | 0.7 | 0.9 | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 4.6 | 6.1 | · | · | · | 2.3 | · | · | · | · | · | 1.3 |
Stopy Wzrostu 7
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 10.2% | -6.8% | 10.9% | 1294.0% | -65.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 4.5% | 143.4% | 75.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 41.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -60.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -12.6% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -44.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 31.8% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 13
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $117M | $106M | $113M | $102M | $7M | $21M | · | $6.0K | $1M | $248.0K | $248.0K | $275.0K | |
| Net Income TTM | $10M | $18M | $-85M | $4M | $-88M | $-56M | $-55M | $-30M | $-22M | $-17M | $-15M | $-7M | |
| Market Cap | $645M | $1.04B | $1.97B | $300M | · | $2.09B | $1.23B | · | $1.24B | $117M | $8.05B | $139.98B | |
| P/E | 353.0 | 242.0 | -18.2 | 265.0 | -4.8 | -64.8 | -70.0 | -81.1 | -140.1 | -100.2 | -482.4 | -2837.2 | |
| P/S | 5.5 | 9.9 | 17.3 | 2.9 | · | 99.8 | · | · | 1222.2 | 472.8 | 32458.2 | 509025.8 | |
| P/B | 6.1 | 16.5 | -124.3 | -13.8 | · | 27.5 | 18.0 | · | 40.4 | 7.3 | 256.2 | 1283.2 | |
| P / Tangible Book | 6.4 | 16.6 | · | 7.1 | 10.4 | 27.5 | · | · | · | · | · | · | |
| P / Cash Flow | 638.3 | -286.8 | 76.0 | -9.1 | · | -38.0 | -28.2 | · | -62.4 | -6.3 | -421.1 | -4059.5 | |
| P / FCF | -3581.5 | -175.3 | 113.3 | · | · | · | -28.2 | · | -62.3 | -6.2 | -415.1 | -4059.0 | |
| Dividend Yield | · | · | · | 15.0% | · | · | · | · | · | · | · | · | |
| Earnings Yield | 0.28% | 0.41% | -5.5% | 0.38% | -21.0% | -1.5% | -1.4% | -1.2% | -0.71% | -1.0% | -0.21% | -0.04% | |
| Payout Ratio | · | · | · | -546.4% | · | · | · | · | · | · | · | · | |
| Annual Payout | · | · | · | $45M | · | · | · | · | · | · | · | · |
Rachunek zysków i strat 16
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $29M | $23M | $37M | $31M | $30M | $22M | $28M | $25M | $25M | $27M | $27M | $32M | $29M | $25M | · | · | |
| Cost of Revenue | $2M | $1M | $2M | $2M | $1M | $894.0K | $1M | $958.0K | $770.0K | $979.0K | $1M | $1M | $1M | $1M | · | · | |
| Gross Profit | · | · | · | $29M | $26M | $21M | · | $25M | $24M | $26M | $26M | $31M | $28M | $24M | · | · | |
| R&D Expense | · | $7M | $5M | $2M | $8M | $3M | $4M | $3M | $3M | $2M | $5M | $3M | $4M | $3M | · | $803.0K | |
| SG&A Expense | $8M | $7M | $7M | $4M | $7M | $5M | $5M | $4M | $3M | $3M | $10M | $1M | $2M | $2M | $4M | $4M | |
| Operating Expenses | $43M | $32M | $41M | $22M | $32M | $20M | $30M | $20M | $21M | $18M | $118M | $18M | $23M | $17M | $119M | $5M | |
| Operating Income | $-14M | $-9M | $118.0K | $7M | $-2M | $2M | $665.0K | $4M | $3M | $8M | $-92M | $13M | $5M | $7M | $-22M | $-5M | |
| Other Non-op | $-943.0K | $29.0K | $-2M | $727.0K | $-488.0K | $107.0K | $-2M | $-75.0K | $-72.0K | $122.0K | $-237.0K | $-1M | $629.0K | · | · | $-1.0K | |
| Pretax Income | $-14M | $-9M | $-66.0K | $8M | $-2M | $5M | $772.0K | $4M | $6M | $12M | $-100M | $11M | $6M | $6M | $-23M | $-5M | |
| Income Tax | $-164.0K | $621.0K | $1M | $2M | $662.0K | $901.0K | $203.0K | $1M | $1M | $3M | $699.0K | $4M | $2M | $2M | $5M | $0 | |
| Net Income | $-14M | $-19M | $-1M | $6M | $-2M | $5M | $569.0K | $3M | $5M | $10M | $-101M | $8M | $4M | $4M | $-28M | $-5M | |
| EPS (Basic) | $-0.12 | $-0.10 | $-0.01 | $0.04 | $-0.02 | $0.03 | $0.00 | $0.01 | $0.04 | $0.09 | $-1.54 | $0.06 | $0.03 | $0.04 | $-0.98 | $-0.16 | |
| EPS (Diluted) | $-0.12 | $-0.10 | $-0.01 | $0.03 | $-0.03 | $0.00 | $0.00 | $0.01 | $0.01 | $0.03 | $-1.51 | $0.05 | $0.02 | $0.03 | $-0.99 | $-0.16 | |
| Shares (Basic) | 100,637,599 | 91,317,142 | -177,045,292 | 90,850,040 | 89,119,344 | 86,420,530 | -169,316,980 | 85,643,646 | 85,502,403 | 83,265,879 | -124,932,682 | 63,588,119 | 63,588,119 | 63,588,119 | -30,829,566 | 31,484,542 | |
| Shares (Diluted) | 100,637,599 | 91,344,584 | -205,463,888 | 103,971,546 | 89,203,138 | 101,970,672 | -205,146,932 | 102,640,373 | 102,205,888 | 102,594,197 | -170,898,339 | 78,904,324 | 78,904,324 | 78,921,366 | -18,737,151 | 31,484,542 | |
| EBITDA | · | $-9M | · | $7M | $2M | $3M | · | $4M | $3M | $8M | · | $-2M | $-3M | $181.0K | · | $-5M |
Bilans 25
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $43M | $38M | $37M | $40M | $36M | $15M | $12M | $16M | $16M | $30M | $34M | $2M | $7M | $8M | $25M | $23M | |
| Short-term Investments | $14M | $12M | $15M | $20M | $18M | $15M | $15M | $9M | $9M | $8M | · | · | · | · | · | · | |
| Receivables | $28M | $23M | $31M | $26M | $25M | $20M | $20M | · | · | · | $15M | · | · | · | · | · | |
| Inventory | $11M | $11M | · | · | $9M | $8M | · | $6M | $6M | $5M | $4M | · | · | · | $6M | · | |
| Prepaid Expense | $8M | $4M | · | $3M | $3M | $8M | · | · | · | · | · | · | $697.0K | $915.0K | · | $2M | |
| Other Current Assets | · | · | $1M | · | · | · | $1M | $2M | $2M | $2M | $1M | · | · | · | $843.0K | · | |
| Current Assets | $122M | $92M | $102M | $99M | $91M | $68M | $65M | $55M | $54M | $63M | $57M | $5M | $8M | $14M | $50M | $30M | |
| PP&E (Net) | $27M | $24M | $24M | $24M | $23M | $24M | $24M | $24M | $24M | $24M | $23M | · | · | $1.0K | $18M | $124.0K | |
| PP&E (Gross) | $40M | $32M | $31M | $31M | $30M | $30M | $29M | $30M | $28M | $28M | $28M | · | · | · | $22M | · | |
| Accum. Depreciation | $13M | $8M | $8M | $7M | $6M | $6M | $6M | $5M | $5M | $5M | $4M | · | · | · | $4M | · | |
| Intangibles | $5M | $5M | $5M | $5M | $5M | $5M | $273.0K | $184.0K | $186.0K | $196.0K | $205.0K | · | · | · | $297.0K | · | |
| Other Non-current Assets | $7M | $5M | $2M | $5M | $5M | $6M | $3M | $3M | $1M | $802.0K | $995.0K | $168.0K | $168.0K | $168.0K | $3M | $168.0K | |
| Total Assets | $199M | $162M | $166M | $159M | $153M | $130M | $125M | $125M | $121M | $122M | $117M | $10M | $12M | $19M | $85M | $31M | |
| Accounts Payable | $1M | $265.0K | $124.0K | $556.0K | $71.0K | $122.0K | $108.0K | $303.0K | $271.0K | $330.0K | $355.0K | $158.0K | $5.0K | $16.0K | $122.0K | $41.0K | |
| Current Liabilities | $29M | $20M | $18M | $16M | $17M | $19M | $20M | $15M | $16M | $19M | $20M | $2M | $3M | $7M | $12M | $2M | |
| Capital Leases | $2M | $72.0K | $303.0K | $539.0K | $771.0K | $780.0K | $885.0K | $1M | $1M | $175.0K | $199.0K | · | · | · | $121.0K | · | |
| Other Non-current Liabilities | $70.0K | $1M | $1M | $1M | $1M | $1M | $7.0K | $2.0K | $47.0K | $48.0K | $49.0K | · | · | · | $55.0K | · | |
| Total Liabilities | $34M | $25M | $24M | $22M | $23M | $25M | $27M | $27M | $28M | $33M | $38M | $6M | $7M | $11M | $13M | $2M | |
| Common Stock | $106.0K | $91.0K | $91.0K | $91.0K | $91.0K | $87.0K | $86.0K | $85.0K | $85.0K | $85.0K | $77.0K | $37.0K | $37.0K | $37.0K | $64.0K | $31.0K | |
| Paid-in Capital | $241M | $175M | $172M | $167M | $161M | $138M | $136M | $134M | $134M | $133M | $68M | $385M | $385M | $385M | $33M | $400M | |
| Retained Earnings | $-138M | $-78M | $-68M | $-67M | $-70M | $-71M | $-73M | $-73M | $-74M | $-78M | $-86M | $-415M | $-413M | $-411M | $7M | $-370M | |
| AOCI | $1M | $586.0K | $-779.0K | $-2M | $-2M | $-2M | $-3M | $-946.0K | $-2M | $-2M | $-2M | · | · | · | $-392.0K | · | |
| Stockholders' Equity | $108M | $101M | $106M | $102M | $92M | $68M | $63M | $63M | $60M | $57M | $-16M | $4M | $-28M | $-26M | $43M | $29M | |
| Liabilities + Equity | $199M | $162M | $166M | $159M | $153M | $130M | $125M | $125M | $121M | $122M | $117M | $10M | $12M | $19M | $85M | $31M | |
| Shares Outstanding | 106,033,763 | 91,337,121 | 91,314,007 | 90,890,381 | 90,822,828 | 87,636,209 | 86,307,544 | 85,769,526 | 85,537,774 | 85,423,246 | 76,595,616 | 37,978,142 | 37,974,892 | 37,759,825 | 63,588,119 | 31,490,053 |
Przepływy pieniężne 14
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $672.0K | $656.0K | $649.0K | $641.0K | $535.0K | $461.0K | $445.0K | $228.0K | $415.0K | $298.0K | $772.0K | $581.0K | $276.0K | $867.0K | $40.0K | |
| Stock-based Comp | $2M | $3M | $5M | $1M | $906.0K | $507.0K | $567.0K | $237.0K | $16.0K | $11.0K | $7M | $98.0K | $89.0K | $210.0K | $12M | $224.0K | |
| Amort. of Intangibles | $179.0K | $175.0K | $172.0K | $170.0K | $167.0K | $67.0K | $-80.5K | $10.0K | $8.5K | $100.0K | $-7.0K | $14.0K | $48.0K | $45.0K | · | · | |
| Other Non-cash | · | $10M | · | · | · | $-5M | · | · | · | $-7M | · | · | · | $-7M | · | · | |
| Operating Cash Flow | $-17M | $3M | $-6M | $5M | $2M | $-129.0K | $-3M | $2M | $-5M | $3M | $3M | $31M | $21M | $10M | $42M | $-7M | |
| CapEx | $262.0K | $178.0K | $144.0K | $668.0K | $256.0K | $122.0K | $-65.0K | $693.0K | $1M | $231.0K | $2M | $2M | $2M | $2M | · | · | |
| Investing Cash Flow | $10M | $-3M | $2M | $-1M | $-3M | $2M | $-2M | $-2M | $-8M | $-7M | $1M | $-26M | $-16M | $-8M | $-69M | $0 | |
| Stock Issued | · | · | · | · | $22M | $509.0K | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | $509.0K | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid | · | · | · | · | · | · | · | · | · | · | · | $2M | $4M | $8M | · | · | |
| Financing Cash Flow | $-8.0K | $21.0K | $318.0K | $365.0K | $22M | $1M | $964.0K | $324.0K | $156.0K | $658.0K | $15M | $-1M | $-4M | $-8M | · | $-45M | |
| Net Change in Cash | $-6M | $431.0K | $-3M | $4M | $21M | $3M | $-4M | $-231.0K | $-14M | $-4M | $7M | $16M | $12M | $3M | $16M | $-52M | |
| Taxes Paid | · | $1M | $1M | $687.0K | $447.0K | $3M | $761.0K | $537.0K | $6M | $1M | $961.0K | $1M | $4M | $463.0K | · | · | |
| Free Cash Flow | · | $3M | · | · | · | $-251.0K | · | · | · | $3M | · | · | · | · | · | · |
Rentowność 8
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | 94.7% | 95.7% | 96.0% | · | 96.2% | 97.0% | 96.4% | · | · | · | · | · | · | |
| Operating Margin | · | -41.5% | · | 22.7% | 8.1% | 10.3% | · | 16.6% | 12.9% | 29.7% | · | · | · | · | · | · | |
| Net Margin | · | -43.8% | · | 19.4% | 5.9% | 16.9% | · | 11.2% | 18.0% | 36.6% | · | · | · | · | · | · | |
| Pretax Margin | · | -41.0% | · | 25.0% | 8.4% | 21.0% | · | 15.4% | 23.9% | 45.9% | · | · | · | · | · | · | |
| EBITDA Margin | · | -38.6% | · | 22.7% | 8.1% | 12.7% | · | 16.6% | 12.9% | 31.2% | · | · | · | · | · | · | |
| ROA | · | -6.8% | · | 4.2% | 1.1% | 3.0% | · | 4.2% | 6.8% | 14.1% | · | -7.7% | -5.2% | 0.88% | · | -8.9% | |
| ROE | · | -11.6% | · | 7.2% | 2.1% | 6.0% | · | 8.6% | 28.3% | 64.8% | · | -9.6% | -9.7% | 46.0% | · | -10.8% | |
| ROIC | · | -9.8% | · | 5.3% | 1.7% | 2.7% | · | 4.9% | 4.1% | 11.3% | · | -46.2% | 9.0% | -0.65% | · | · |
Płynność i wypłacalność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 4.6 | · | 6.2 | 5.4 | 3.6 | · | 3.7 | 3.4 | 3.2 | · | 2.9 | 2.7 | 2.0 | · | 18.4 | |
| Quick Ratio | · | 3.7 | · | 5.4 | 4.7 | 2.6 | · | 1.7 | 1.6 | 1.9 | · | 1.2 | 2.5 | 1.2 | · | 14.0 |
Efektywność 3
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.4 | 0.4 | 0.4 | · | · | · | · | · | · | |
| Inventory Turnover | · | 0.1 | · | · | 0.2 | 0.1 | · | 0.3 | 0.3 | 0.4 | · | · | · | · | · | · | |
| Receivables Turnover | · | 1.0 | · | 2.3 | 2.0 | 2.1 | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 11
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $112M | $102M | · | $105M | $100M | $100M | · | $110M | $114M | $113M | · | · | · | · | · | $6M | |
| Net Income TTM | $-29M | $1M | · | $14M | $13M | $21M | · | $25M | $26M | $25M | · | $11M | $55M | $36M | · | $7M | |
| Market Cap | · | $637M | · | $678M | $668M | $677M | · | $1.08B | $1.02B | $1.49B | · | $273M | $199M | $119M | · | $236M | |
| P/E | -30.0 | -99.6 | · | 186.5 | 367.5 | 154.4 | · | 125.4 | 108.5 | 134.5 | · | -120.0 | 3.4 | 3.0 | · | 34.1 | |
| P/S | · | 6.2 | · | 6.5 | 6.7 | 6.8 | · | 9.8 | 9.0 | 13.2 | · | · | · | · | · | 41.5 | |
| P/B | · | 6.3 | · | 6.7 | 7.3 | 9.9 | · | 17.0 | 16.9 | 26.4 | · | 77.7 | -7.0 | -4.6 | · | 8.0 | |
| P / Tangible Book | 6.8 | 6.6 | · | 7.0 | 7.7 | 10.7 | · | 17.1 | 17.0 | 26.5 | · | 77.7 | · | · | · | 8.0 | |
| P / Cash Flow | · | 200.2 | · | · | · | -5244.6 | · | · | · | 517.8 | · | · | · | -19.1 | · | · | |
| P / FCF | · | 212.1 | · | · | · | -2695.4 | · | · | · | 562.8 | · | · | · | · | · | · | |
| Earnings Yield | -3.3% | -1.0% | · | 0.54% | 0.27% | 0.65% | · | 0.80% | 0.92% | 0.74% | · | -0.83% | 29.1% | 33.3% | · | 2.9% | |
| Payout Ratio | · | · | · | · | · | · | · | · | · | · | · | · | · | 2986.2% | · | · |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $117M | $106M | $113M | $102M | $7M |
| Marża Brutto % | — | 96.3% | 95.9% | — | — |
| Marża Operacyjna % | 9.8% | 15.3% | -59.3% | — | — |
| Zysk netto | $10M | $18M | $-85M | $4M | $-88M |
| Rozwodniony EPS | $0.02 | $0.05 | $-1.41 | $0.03 | $-2.87 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 5.6 | 3.3 | 2.9 | 1.7 | — |
| Wskaźnik Szybkości | 4.6 | 2.4 | 1.7 | 1.3 | — |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-180.0K | $-6M | $17M | — | — |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 63 emitenci · $55.4M łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 17 (+6 vs poprzedni kw.) | 7 (+4 vs poprzedni kw.) | 26 (+8 vs poprzedni kw.) | 8 (0 vs poprzedni kw.) | +6.1M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| HSG Holding Ltd | $24 714 470 | 3 750 299 | 44,65% | Akcje |
| VANGUARD GROUP INC | $7 437 901 | 1 053 527 | 13,44% | Akcje |
| Octagon Capital Advisors LP | $6 289 601 | 954 416 | 11,36% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $5 778 949 | 876 927 | 10,44% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $3 006 906 | 456 126 | 5,43% | Akcje |
| STATE STREET CORP | $1 617 199 | 245 402 | 2,92% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1 214 445 | 184 286 | 2,19% | Akcje |
| SBI Securities Co., Ltd. | $1 098 883 | 166 750 | 1,99% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $995 571 | 151 073 | 1,80% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $816 850 | 123 953 | 1,48% | Akcje |
| GOLDMAN SACHS GROUP INC | $568 289 | 86 235 | 1,03% | Akcje |
| Bank of New York Mellon Corp | $227 935 | 34 588 | 0,41% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $171 392 | 24 590 | 0,31% | Akcje |
| STRS OHIO | $170 022 | 25 800 | 0,31% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $161 521 | 24 510 | 0,29% | Akcje |
| Nuveen, LLC | $161 488 | 24 505 | 0,29% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $121 836 | 18 488 | 0,22% | Akcje |
| RHUMBLINE ADVISERS | $111 131 | 16 865 | 0,20% | Akcje |
| FMR LLC | $98 679 | 14 974 | 0,18% | Akcje |
| BANK OF AMERICA CORP /DE/ | $82 539 | 12 525 | 0,15% | Akcje |
| Polymer Capital Management (US) LLC | $77 630 | 11 780 | 0,14% | Akcje |
| Vanguard Global Advisers, LLC | $65 788 | 9 983 | 0,12% | Akcje |
| Police & Firemen's Retirement System of New Jersey | $59 382 | 9 011 | 0,11% | Akcje |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $55 659 | 8 446 | 0,10% | Akcje |
| CITIGROUP INC | $49 603 | 7 527 | 0,09% | Akcje |
| BlackRock, Inc. | $28 752 | 4 363 | 0,05% | Akcje |
| Russell Investments Group, Ltd. | $23 803 | 3 612 | 0,04% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $22 973 | 3 486 | 0,04% | Akcje |
| NORTHERN TRUST CORP | $18 887 | 2 866 | 0,03% | Akcje |
| BARCLAYS PLC | $18 558 | 2 816 | 0,03% | Akcje |
| NEW YORK STATE COMMON RETIREMENT FUND | $17 793 | 2 700 | 0,03% | Akcje |
| Tower Research Capital LLC (TRC) | $16 271 | 2 469 | 0,03% | Akcje |
| MORGAN STANLEY | $16 106 | 2 444 | 0,03% | Akcje |
| Legal & General Group Plc | $13 536 | 2 054 | 0,02% | Akcje |
| Ameritas Investment Partners, Inc. | $4 501 | 683 | 0,01% | Akcje |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $4 454 | 639 | 0,01% | Akcje |
| ROYAL BANK OF CANADA | $4 000 | 537 | 0,01% | Akcje |
| Activest Wealth Management | $3 512 | 533 | 0,01% | Akcje |
| Arax Advisory Partners | $1 621 | 246 | 0,00% | Akcje |
| MERCER GLOBAL ADVISORS INC /ADV | $1 285 | 195 | 0,00% | Akcje |
| Sterling Capital Management LLC | $1 061 | 161 | 0,00% | Akcje |
| GAMMA Investing LLC | $962 | 146 | 0,00% | Akcje |
| CWM, LLC | $725 | 104 | 0,00% | Akcje |
| Physician Wealth Advisors, Inc. | $541 | 82 | 0,00% | Akcje |
| Bare Financial Services, Inc | $521 | 79 | 0,00% | Akcje |
| WELLS FARGO & COMPANY/MN | $435 | 66 | 0,00% | Akcje |
| JPMORGAN CHASE & CO | $361 | 56 | 0,00% | Akcje |
| GoalVest Advisory LLC | $330 | 50 | 0,00% | Akcje |
| Allworth Financial LP | $251 | 38 | 0,00% | Akcje |
| DEUTSCHE BANK AG\ | $244 | 37 | 0,00% | Akcje |
| OSAIC HOLDINGS, INC. | $216 | 33 | 0,00% | Akcje |
| UBS Group AG | $165 | 25 | 0,00% | Akcje |
| PRICE T ROWE ASSOCIATES INC /MD/ | $100 | 15 031 | 0,00% | Akcje |
| Caitong International Asset Management Co., Ltd | $99 | 15 | 0,00% | Akcje |
| Integrated Wealth Concepts LLC | $94 | 14 | 0,00% | Akcje |
| EverSource Wealth Advisors, LLC | $53 | 8 | 0,00% | Akcje |
| Farther Finance Advisors, LLC | $53 | 8 | 0,00% | Akcje |
| Optiver Holding B.V. | $40 | 6 | 0,00% | Akcje |
| Smartleaf Asset Management LLC | $39 | 6 | 0,00% | Akcje |
| State of Alaska, Department of Revenue | $34 | 5 219 | 0,00% | Akcje |
| ROTHSCHILD INVESTMENT LLC | $7 | 1 | 0,00% | Akcje |
| Essential Partners LLC | $7 | 1 | 0,00% | Akcje |
| Covestor Ltd | $0 | 48 | 0,00% | Akcje |
Insiderzy spółki 66 insiderów · 26 dyrektorzy generalni · 32 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Ying Luo | Chief Executive Officer | 8 czerwca 2026 A | 2 565 226 | 0 | 2 | $-82 927 |
| Han Ying | Chief Executive Officer | 14 sierpnia 2024 A | — | 0 | 0 | $0 |
| Charles C Wu | Chief Executive Officer | 20 listopada 2023 A | — | 0 | 0 | $0 |
| Donald J Debethizy | President and CEO | 4 maja 2012 A | 798 | 0 | 0 | $0 |
| Thomas Wilson Eastling | Chief Financial Officer | 4 maja 2026 A | 15 000 | 0 | 0 | $0 |
| Ruoyu Chen | Chief Financial Officer | 7 stycznia 2026 A | — | 0 | 0 | $0 |
| Seline E. Miller | SVP Finance; Interim CFO & PAO | 31 sierpnia 2023 D | 0 | 0 | 0 | $0 |
| Clinton Musil | Chief Financial Officer | 8 lutego 2021 A | — | 0 | 0 | $0 |
| Fletcher Payne | Chief Financial Officer | 12 sierpnia 2019 A | 3 744 | 0 | 0 | $0 |
| Mauri K Hodges | Treasurer, CFO | 14 sierpnia 2015 A | 1 159 | 0 | 0 | $0 |
| Alan A Musso | SVP, Fin+Admin, CFO & Treas | 17 października 2014 A | 57 799 | 0 | 0 | $0 |
| Songjiang Ma | President | 28 maja 2025 S | 2 806 084 | 0 | 0 | $0 |
| Weiguo Ye | Chief Operating Officer | 18 czerwca 2026 M | 700 000 | 0 | 16 | $-869 947 |
| Joshua Benjamin Bergmann | GC and Corporate Secretary | 8 czerwca 2026 A | — | 0 | 0 | $0 |
| Grant E. Blouse | Chief Scientific Officer | 9 sierpnia 2022 P | 9 417 | 0 | 0 | $0 |
| Howard Levy | Chief Medical Officer | 9 sierpnia 2021 P | 639 | 0 | 0 | $0 |
| Veronica Cai | Controller | 13 marca 2020 P | 7 353 | 0 | 0 | $0 |
| Edwin Madison | Chief Scientific Officer | 22 października 2015 A | 31 008 | 0 | 0 | $0 |
| Patrick C. Rock | Secretary, GC | 14 sierpnia 2015 A | 45 000 | 0 | 0 | $0 |
| Steven M. Toler | VP, Clin Pharm Sciences | 17 października 2014 A | 46 000 | 0 | 0 | $0 |
| David A. Hosford | VP, Clin Dev & Reg Affairs | 23 stycznia 2014 A | — | 0 | 0 | $0 |
| Karen A Hicks | VP, Human Resources | 17 stycznia 2013 A | 0 | 0 | 0 | $0 |
| Peter A Zorn | SVP, Lgl Affrs, GC & Secretary | 17 stycznia 2013 A | 0 | 0 | 0 | $0 |
| Merouane Bencherif | SVP and Senior Scien Fellow | 17 stycznia 2013 A | 15 938 | 0 | 0 | $0 |
| William S Caldwell | SVP - Drug Discovery and Dev. | 20 września 2011 G | 500 | 0 | 0 | $0 |
| Geoffrey C Dunbar | SVP, Clin. Dev. & Reg. Affairs | 29 marca 2011 A | 1 153 | 0 | 0 | $0 |
| Claire Weston | Dyrektor | 3 sierpnia 2026 A | — | 0 | 0 | $0 |
| Maxwell Kirkby | Dyrektor | 3 sierpnia 2026 A | — | 0 | 0 | $0 |
| Dan Weng | Dyrektor | 10 czerwca 2026 A | — | 0 | 0 | $0 |
| Ping Zhang | Dyrektor | 10 czerwca 2026 A | — | 0 | 0 | $0 |
| Rodney L Nussbaum | Dyrektor | 10 czerwca 2026 A | — | 0 | 0 | $0 |
| Renate Parry | Dyrektor | 10 czerwca 2026 A | — | 0 | 0 | $0 |
| Gordon Carmichael | Dyrektor | 10 czerwca 2026 A | — | 0 | 0 | $0 |
| David M. Epstein | Dyrektor | 10 czerwca 2026 A | — | 0 | 0 | $0 |
| Nassim Usman | Dyrektor | 28 czerwca 2024 M | 1 636 | 0 | 0 | $0 |
| Andrea Hunt | Dyrektor | 31 sierpnia 2023 D | 0 | 0 | 0 | $0 |
| Augustine Lawlor | Dyrektor | 31 sierpnia 2023 D | 0 | 0 | 0 | $0 |
| Geoffrey Ling M.D. | Dyrektor | 7 stycznia 2022 A | 31 790 | 0 | 0 | $0 |
| Eddie Williams | Dyrektor | 7 stycznia 2022 A | 34 804 | 0 | 0 | $0 |
| Errol B Desouza | Dyrektor | 1 października 2021 A | 29 801 | 0 | 0 | $0 |
| Jeanne Y Jew | Dyrektor | 9 września 2021 A | — | 0 | 0 | $0 |
| Sharon Tetlow | Dyrektor | 9 czerwca 2021 A | 3 635 | 0 | 0 | $0 |
| John P Richard | Dyrektor | 13 marca 2020 P | 3 716 | 0 | 0 | $0 |
| Stephen A Hill | Dyrektor | 6 września 2018 D | 1 190 | 0 | 0 | $0 |
| Harold E Selick | Dyrektor | 16 stycznia 2018 A | 16 614 | 0 | 0 | $0 |
| Jeff Himawan | Dyrektor | 20 sierpnia 2015 J | 1 179 352 | 0 | 0 | $0 |
| Alan W Dunton | Dyrektor | 14 sierpnia 2015 A | 10 000 | 0 | 0 | $0 |
| Charles A Blixt | Dyrektor | 14 sierpnia 2015 A | 10 000 | 0 | 0 | $0 |
| Julia R Brown | Dyrektor | 14 sierpnia 2015 A | 10 000 | 0 | 0 | $0 |
| SKALETSKY MARK B | Dyrektor | 7 czerwca 2013 A | 11 332 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 21 akcji
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Songjiang Ma, Yueying Zhu | 7 maja 2026 | 6,33% | Aneks | — | SEC |
| Ying Luo, Ping Lan | 6 maja 2026 | 8,60% | Aneks | — | SEC |
| GNI USA, Inc., GNI Group Ltd. ×4 zgłoszenia | 6 maja 2026 | 69,10% | Aneks | — | SEC |
| Ying Luo (“Mr. Luo”), Ping Lan | 6 września 2024 | — | Pierwotne zgłoszenie | — | SEC |
| Songjiang Ma (“Mr. Ma”), Yueying Zhu | 6 września 2024 | — | Pierwotne zgłoszenie | — | SEC |
| GNI Group Ltd., GNI Hong Kong Limited, GNI USA, Inc. ×2 zgłoszenia | 31 października 2023 | — | Pierwotne zgłoszenie | — | SEC |
| JDS1, LLC, CCUR Holdings, Inc., CIDM II, LLC, Julian D. Singer, David S. Oros ×13 zgłoszenia | 7 października 2022 | — | Pierwotne zgłoszenie | — | SEC |
| JEC II Associates, LLC, The Heidi S. Shippell-Heiland 2008 Irrevocable Trust, Michael Torok ×4 zgłoszenia | 22 września 2022 | — | Pierwotne zgłoszenie | — | SEC |
| Julian Singer, JDS1, LLC 2, CCUR Holdings, Inc., David S. Oros ×3 zgłoszenia | 27 stycznia 2022 | — | Pierwotne zgłoszenie | — | SEC |
| 22NW Fund, LP, 22 NW, LP, 22NW Fund GP, LLC, 22NW GP, Inc., Aron R. English ×2 zgłoszenia | 5 sierpnia 2020 | — | Pierwotne zgłoszenie | — | SEC |
| CCUR Holdings, Inc., Wayne Barr, Jr., JDS1, LLC, David S. Oros, Julian Singer ×3 zgłoszenia | 17 stycznia 2020 | — | Pierwotne zgłoszenie | — | SEC |
| Morgenthaler Management Partners VIII, LLC (“MMP VIII”), Morgenthaler Partners VIII, L.P. (“MP VIII”), Robert C. Bellas, Jr. (“Bellas”), Ralph E. Christoffersen (“Christoffersen”), John Lutsi (“Lutsi”), Gary J. Morgenthaler (“Morgenthaler”), Robert D. Pavey (“Pavey”), Gary R. Little (“Little”) | 14 lutego 2018 | — | Pierwotne zgłoszenie | — | SEC |
| HealthCare Ventures VIII, L.P., HealthCare Partners VIII, L.P., HealthCare Partners VIII, LLC, James H. Cavanaugh, Ph.D., Harold R. Werner, John W. Littlechild, Christopher Mirabelli, Ph.D., Augustine Lawlor ×2 zgłoszenia | 9 lutego 2018 | — | Pierwotne zgłoszenie | — | SEC |
| 23 maja 2017 | — | Pierwotne zgłoszenie | — | SEC | |
| New Enterprise Associates 10, Limited Partnership, NEA Partners 10, Limited Partnership, Michael James Barrett, Peter J. Barris, Scott D. Sandell ×4 zgłoszenia | 29 marca 2017 | — | Pierwotne zgłoszenie | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 18 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| IWO · iShares Trust | 0,01% | 117 803 SH | 8 sierpnia 2026 | Dziennie |
| IWM · iShares Trust | 0,00% | 386 378 SH | 8 sierpnia 2026 | Dziennie |
| RSSL · Global X Funds | 0,00% | 5 185 NS | 30 kwietnia 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,00% | 99 892 NS | 31 maja 2026 | N-PORT |
| IWN · iShares Trust | 0,00% | 41 237 SH | 8 sierpnia 2026 | Dziennie |
| ITWO · ProShares Trust | 0,00% | 555 NS | 31 maja 2026 | N-PORT |
| UWM · ProShares Trust | 0,00% | 435 NS | 31 maja 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 441 NS | 31 maja 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 1 907 NS | 31 maja 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 11 NS | 31 maja 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 18 000 NS | 31 maja 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 238 693 SH | 8 sierpnia 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 614 654 SH | 8 sierpnia 2026 | Dziennie |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 104 607 SH | 8 sierpnia 2026 | Dziennie |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,00% | 5 047 SH | 8 sierpnia 2026 | Dziennie |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 13 494 SH | 8 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 805 SH | 8 sierpnia 2026 | Dziennie |
| DFAS · Dimensional ETF Trust | 0,00% | 320 NS | 30 kwietnia 2026 | N-PORT |